Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin and Simvastatin PK in Pediatric Dyslipidemia
NCT02360826Phase 1Completed
- Sponsor
- Children's Mercy Kansas City
- Start
- Jun 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pravastatin and simvastatin in dyslipidemia, sponsored by Children's Mercy Kansas City. Primary endpoint: Maximum Plasma Concentration of Pravastatin at 8 hours. Started Jun 2014; status: completed.
02
Drugs
pravastatinsimvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT02360826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02360826.